Steven Cohen’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.77M Buy
11,800
+1,700
+17% +$185K ﹤0.01% 2471
2026
Q1
$933K Buy
+10,100
New +$1.01M ﹤0.01% 2805
2024
Q2
Sell
-45,000
Closed -$928K 2071
2024
Q1
$928K Sell
45,000
-25,000
-36% -$536K ﹤0.01% 1481
2023
Q4
$1.89M Buy
+70,000
New +$1.84M ﹤0.01% 1228
2023
Q1
Sell
-12,500
Closed -$340K 2353
2022
Q4
$340K Buy
+12,500
New +$572K ﹤0.01% 1196

Other funds holding GH

Steven Cohen's GH Position: Q2 2026 in Review

Steven Cohen increased its Guardant Health (GH) stake by 32% in Q2 2026, buying an estimated $24.5M and bringing the position to 920,807 shares worth $138M. The position accounts for 0.15% of the portfolio, ranked #134.

Steven Cohen first reported a position in GH in Q1 2019 and has held it in 20 quarters since. The position peaked at $153M in Q4 2025. 595 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Steven Cohen held 920,807 shares of Guardant Health worth $138M as of Q2 2026.
  • Steven Cohen bought 224,867 Guardant Health shares in Q2 2026, an estimated $24.5M.
  • Guardant Health made up 0.15% of Steven Cohen's portfolio in Q2 2026, its #134 holding.
  • Steven Cohen first reported a position in Guardant Health in Q1 2019 and has held it in 20 quarters since.
  • Steven Cohen's Guardant Health position peaked at $153M in Q4 2025.
  • 595 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.